Russian Association of Endocrinologists reports commencement of Trajenta clinical use
Guardado en:
Autor principal: | Editorial team Diabetes Mellitus |
---|---|
Formato: | article |
Lenguaje: | EN RU |
Publicado: |
Endocrinology Research Centre
2012
|
Materias: | |
Acceso en línea: | https://doaj.org/article/fbeca3c5dbc146cc9c935f247bbc1bb4 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Expert committee on novel DPP-4 inhibitor TRADJENTA (linagliptin) in treatment of type 2 diabetes mellitus
por: Editorial team Diabetes Mellitus
Publicado: (2012) -
Biopharmaceuticals. Official position of Russian Association of Endocrinologists
por: Editorial team Diabetes Mellitus
Publicado: (2013) -
Russian Association of Endocrinologists about the introduction of Diabeton MR (60 mg tablets)
por: Editorial team Diabetes Mellitus
Publicado: (2011) -
Russian Association of Endocrinologists reports commencement of Amaril clinical use
por: Editorial team Diabetes Mellitus
Publicado: (2012) -
Russian Association of Endocrinologists reports commencement of Glimecomb clinical use
por: Editorial team Diabetes Mellitus
Publicado: (2011)